THE PRODUCTION OF PURPURA BY DERIVATIVES OF PNEUMOCOCCUS : II. THE EFFECT OF PNEUMOCOCCUS EXTRACT ON THE BLOOD

H A Reimann1, L A Julianelle

  • 1Hospital of The Rockefeller Institute for Medical Research.

Insights

Pneumococcus extract significantly reduces blood platelets and red blood cells in mice, causing purpura. While heated extracts lose some activity, they still induce purpura, highlighting the extract's potent effects on blood components.

Area of Science:

  • Hematology
  • Immunology
  • Microbiology

Background:

  • Pneumococcus infections can lead to various complications.
  • The effects of pneumococcus extracts on blood cell counts and coagulation are not fully understood.

Purpose of the Study:

  • To investigate the impact of pneumococcus extract on blood platelets, red blood cells, and white blood cells in mice.
  • To determine the thrombolytic and hemolytic properties of pneumococcus extracts.
  • To assess the role of heat and adsorption in modulating the extract's activity.

Main Methods:

  • White mice were injected with pneumococcus extract.
  • Blood cell counts (platelets, red cells, white cells) were monitored over time.
  • Thrombolytic and hemolytic activity was assessed in vitro.
  • Extracts were subjected to heat treatment and adsorption with blood cells.

Main Results:

  • Pneumococcus extract caused a significant decrease in blood platelets and red blood cells, with purpuric lesions appearing at low platelet counts.
  • Platelet regeneration occurred by day 4-9, with over-regeneration and a 2-week return to normal.
  • The extract exhibited thrombolytic and hemolytic activity in vitro, which was reduced by heat.
  • Heated extract induced purpura but not severe anemia, while adsorbed extracts showed diminished lysin activity but still caused purpura, anemia, and thrombopenia.

Conclusions:

  • Pneumococcus extract has potent thrombolytic and hemolytic effects, leading to significant hematological changes and purpura in mice.
  • Heat treatment partially neutralizes the extract's activity, but residual components can still cause adverse effects.
  • Adsorption studies suggest specific interactions between extract components and blood cells, influencing both in vitro activity and in vivo pathogenicity.

Related Concept Videos

Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps: